Guzman, A. “Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, pp. S103-S104, doi:10.25251/skin.2.supp.98.